// App-Quantinova.ai

: Incorporation of Machine Learning Tools to Predict Global Outcomes for Patients with Relapsed and Refractory Peripheral T and NK/T-Cell Lymphomas in the Contemporary Era

Researchers

Presenter

  • Leora S Boussi

Principal Investigators

  • Xinyi Han

  • Luke peng

  • Min Ji Koh

  • Ijeoma Eche

  • Josie Germain Ford

  • Shambhavi Singh

  • Eliana Miranda

  • Carlos S. Chiattone

  • Carrie Van Der Weyden

  • Henry Miles Prince

  • Francine M. Foss

  • Sang Eun Yoon

  • Won-Seog Kim

  • Girisha Panchoo

  • Estelle Verburgh

  • Jackielyn Cuenca Alturas

  • Mubarak Al-Mansour

  • Martina Manni

  • Massimo Federico

  • Maria Elena Cabrera

  • Beatrice Casadei

  • Pier Luigi Zinzani

  • Noriaki Yoshida

  • Takeshi Okatani

  • Mwanasha H. Merrill

  • Eric D Jacobsen

  • Owen A. O'Connor

  • Enrica Marchi

  • Salvia Jain

Medical Centers

  • College of Science, Northeastern University, Boston, MA

  • Dana Farber Cancer Institute, Boston, MA

  • Hematology Department, Hospital Del Salvador, Santiago, Chile

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

  • Hematology, Yale Cancer Center, New Haven, CT

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Department of Hematology, Peter MacCallum Cancer Center, Melbourne, Australia

  • Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA

  • Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

  • Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia

  • Georgetown University School of Medicine, Washington, DC

  • King Abdulaziz Medical City, Jeddah, Saudi Arabia

  • Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan

  • Department of Medicine, Santa Casa Medicine School, Sao Paulo, Brazil

  • Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA

  • Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy

  • Massachusetts Institute of Technology, Cambridge, MA

  • Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA

  • University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

  • Radiation Effects Research Foundation, Hiroshima-Shi, Japan

Locations

  • United States

  • Australia

  • Saudi Arabia

  • Japan

  • Chile

  • Republic of South Korea

  • Brazil

  • South Africa

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral T-cell lymphoma

  • Adult T-Cell Leukemia

Biomarkers

  • Anaplastic lymphoma Kinase

  • Estrogen receptor alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Efficacy

  • Multinational

  • Global

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved